BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16174542)

  • 1. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.
    Spik K; Shurtleff A; McElroy AK; Guttieri MC; Hooper JW; SchmalJohn C
    Vaccine; 2006 May; 24(21):4657-66. PubMed ID: 16174542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
    Spik KW; Badger C; Mathiessen I; Tjelle T; Hooper JW; Schmaljohn C
    Vaccine; 2008 Sep; 26(40):5177-81. PubMed ID: 18482782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
    Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
    Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological evidence of rift valley fever Phlebovirus and Crimean-Congo hemorrhagic fever orthonairovirus infections among pygmies in the east region of Cameroon.
    Sadeuh-Mba SA; Yonga Wansi GM; Demanou M; Gessain A; Njouom R
    Virol J; 2018 Apr; 15(1):63. PubMed ID: 29625611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
    Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
    Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rift Valley Fever and Crimean-Congo Hemorrhagic Fever Viruses in Ruminants, Jordan.
    Obaidat MM; Graziano JC; Morales-Betoulle M; Brown SM; Chiang CF; Klena JD
    Emerg Infect Dis; 2021; 27(2):653-655. PubMed ID: 33496248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
    de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
    Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence report on tick-borne encephalitis virus and Crimean-Congo hemorrhagic fever virus among Malaysian's farm workers.
    Mohd Shukri M; Ling Kho K; Ghane Kisomi M; Lani R; Marlina S; Muhd Radzi SF; Tee Tay S; Ping Wong L; Awang Mahmud AB; Hassan Nizam QN; Abu Bakar S; Zandi K
    BMC Public Health; 2015 Jul; 15():704. PubMed ID: 26205588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
    Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo stability of the rodent-borne Hantaan virus in comparison to that of arthropod-borne members of the Bunyaviridae family.
    Hardestam J; Simon M; Hedlund KO; Vaheri A; Klingström J; Lundkvist A
    Appl Environ Microbiol; 2007 Apr; 73(8):2547-51. PubMed ID: 17337567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus.
    Garrison AR; Alakbarova S; Kulesh DA; Shezmukhamedova D; Khodjaev S; Endy TP; Paragas J
    Am J Trop Med Hyg; 2007 Sep; 77(3):514-20. PubMed ID: 17827370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.